1-6 of 6
Andrew Robinson
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract LB107: Association of circulating free DNA (cfDNA) maximum variant allele frequency (mVAF) levels with clinical outcomes in patients (pts) with metastatic nonsquamous non-small cell lung cancer (NSCLC) treated with pembrolizumab (pembro) + chemotherapy (chemo) in the phase 2 KEYNOTE-782 trial

Jair Bar, Emilio Esteban, Delvys Rodríguez-Abreu, Santiago Ponce-Aix, Zsuzsanna Szalai, Enriqueta Felip, Maya Gottfried, Mariano Provencio Pulla, Andrew Robinson, Andrea Fülöp, Suman Bannur Rao, D. Ross Camidge, Giovanna Speranza, Nathan Hunkapiller, Robert McDaniel, Byoungsok Jung, David Burkhardt, Ruth Mauntz, Cai Chen, Carol Pena, Razvan Cristescu, Elisha J. Dettman, Steven M. Townson, Julie Kobie, Tibor Csőszi
Journal: Cancer Research
Cancer Res (2024) 84 (7_Supplement): LB107.
https://doi.org/10.1158/1538-7445.AM2024-LB107
Published: 05 April 2024
View article titled, Abstract LB107: Association of circulating free DNA (cfDNA) maximum variant allele frequency (mVAF) levels with clinical outcomes in patients (pts) with metastatic nonsquamous non-small cell lung cancer (NSCLC) treated with pembrolizumab (pembro) + chemotherapy (chemo) in the phase 2 KEYNOTE-782 trial
Journal Articles

Abstract CT216: Response to first-line (1L) pembrolizumab (pembro) + chemotherapy (chemo) in non-small cell lung cancer (NSCLC) by blood tumor mutational burden (bTMB): the phase 2 KEYNOTE-782 trial

Jair Bar, Emilio Esteban, Delvys Rodríguez-Abreu, Santiago Ponce Aix, Zsuzsanna Szalai, Enriqueta Felip, Maya Gottfried, Mariano Provencio Pulla, Andrew Robinson, Andrea Fülöp, Suman B. Rao, D. Ross Camidge, Giovanna Speranza, Steven M. Townson, Julie Kobie, Mark Ayers, Elisha J. Dettman, Robert McDaniel, Byoungsok Jung, David Burkhardt, Ruth Mauntz, Tibor Csőszi
Journal: Cancer Research
Cancer Res (2023) 83 (8_Supplement): CT216.
https://doi.org/10.1158/1538-7445.AM2023-CT216
Published: 14 April 2023
View article titled, Abstract CT216: Response to first-line (1L) pembrolizumab (pembro) + chemotherapy (chemo) in non-small cell lung cancer (NSCLC) by blood tumor mutational burden (bTMB): the phase 2 KEYNOTE-782 trial
Journal Articles

Abstract P3-07-10: CCTG IND.236: A Phase 1b trial of combined CFI-402257 and weekly paclitaxel in patients with HER2-negative (HER2-) advanced breast cancer (aBC)

Philippe Bedard, Mihaela Mates, John Hilton, Nathalie Levasseur, Arif Awan, Amirrtha Srikanthan, David W. Cescon, Karen Gelmon, Andrew Robinson, Nancy Drummond-Ivars, Irene Li, Laleh Rastgou, Jackie Edwards, Linda Hagerman, Siwei Zhang, Mark Bray, Lesley Seymour, Moira Rushton, Pierre-Olivier Gaudreau
Journal: Cancer Research
Cancer Res (2023) 83 (5_Supplement): P3-07-10.
https://doi.org/10.1158/1538-7445.SABCS22-P3-07-10
Published: 01 March 2023
View article titled, Abstract P3-07-10: CCTG IND.236: A Phase 1b trial of combined CFI-402257 and weekly paclitaxel in patients with HER2-negative (HER2-) advanced breast cancer (aBC)
Journal Articles

Abstract P3-07-18: CCTG IND.239: A phase 2 study of combined CFI-400945 and durvalumab in patients with advanced triple negative breast cancer (aTNBC)

John Hilton, David W. Cescon, Andrew Robinson, Sukhbinder Dhesy-Thind, Sara Taylor, Arif Awan, Terry L. Ng, Moira Rushton, Marie-France Savard, Lindsay Muyot, Marie Claude Reeves, Linda Hagerman, Hongbo Lui, Mark Bray, Dongsheng Tu, Lesley Seymour, Pierre-Olivier Gaudreau
Journal: Cancer Research
Cancer Res (2023) 83 (5_Supplement): P3-07-18.
https://doi.org/10.1158/1538-7445.SABCS22-P3-07-18
Published: 01 March 2023
View article titled, Abstract P3-07-18: CCTG IND.239: A phase 2 study of combined CFI-400945 and durvalumab in patients with advanced triple negative breast cancer (aTNBC)
Journal Articles

Multiplexed in situ analysis of protein expression to predict response to trastuzumab

Jena Giltnane, Annette Molinaro, Andrew Robinson, Dmitry Turbin, Karen Gelmon, David Huntsman, David Rimm
Journal: Cancer Research
Cancer Res (2007) 67 (9_Supplement): 5028.
Published: 01 May 2007
View article titled, Multiplexed in situ analysis of protein expression to predict response to trastuzumab
Journal Articles

DNA Ligase and DNase Activities in Mouse Erythroleukemia Cells during Dimethyl Sulfoxide-induced Differentiation

Barbara M. Scher, William Scher, Andrew Robinson, Samuel Waxman
Journal: Cancer Research
Cancer Res (1982) 42 (4): 1300–1306.
Published: 01 April 1982
View article titled, DNA Ligase and DNase Activities in Mouse Erythroleukemia Cells during Dimethyl Sulfoxide-induced Differentiation
Open the PDF for DNA Ligase and DNase Activities in Mouse Erythroleukemia Cells during Dimethyl Sulfoxide-induced Differentiation in another window